realistic and long-Lasting Zero-Fade Faux Foliage

“As Co-Founder & Vistafolia Certified Installer Trainer, 13 years of experience in artificial greening manufacturing, I can assuredly say this planter solution is changing the lives and businesses of people in and new, exciting way.” – Jackie Wiener, Principal UpScapers

NASHVILLE, Tenn. (PRWEB)
May 09, 2023

A new offering by UpScapers has made one brand of faux plants a viable option for those with chronic illness, elderly or people or organizations who simply don’t have the budget or time to care for their potted plants.

Studies have long shown that faux foliage provides many of the same biophilic benefits as live plants. New studies even point to these replica solutions to greenery having less of an overall carbon footprint than their living counterparts, but until now there has not been a viable, realistic, all-weather solution for faux plants.

UpScaper’s is changing this with the introduction of the Flawless Fauxlage (TM) an all-weather potted plant solution with the power of Vistafolia’s proven plant technologies.

In addition to their superior UV performance, freeze/thaw performance and realism, Flawless Fauxliage artificial plants also come in a variety of shapes, styles and colors, giving people the opportunity to customize their planters in ways that aren’t possible with real plants.

Flawless Fauxliage provides plant collections aimed at mood outcomes based on color science or al-a-cart options for homeowners and also provides robust custom solutions for, expansive commercial projects.

“As Co-Founder & Vistafolia Certified Installer Trainer, 13 years of experience in artificial greening manufacturing, I can assuredly say this planter solution is changing the lives and businesses of people in and new, exciting way – and we are energized and delighted by the response we get on every project.” – Jackie Wiener, Principal UpScapers

About UpScapers

Established in 2020, UpScapers designs and installs Vistafolia replica green walls and potted foliage (The Flawless Flowerpot ™), as well as live plant green walls throughout the Americas and surrounding Islands. UpScapers supplies, trains and supports a vast network of certified Vistafolia Resellers and is invested in educating the architectural & design community on biophilic design benefits and the faux greening trend.

About Vistafolia

Established in 2014, Vistafolia designs, manufactures, and supplies unique and versatile ultra-realistic lush artificial green wall systems which are sold globally and work in conjunction with UpScapers to service and train its reseller base in the Americas and surrounding islands.

Share article on social media or email:

Leonard Perlmutter (Ram Lev)
AMI Founder & Curriculum Developer

“The peer-reviewed, clinically proven curriculum presented at the October 17-21 Physicians Conference is the antidote for stress and burnout.” – Leonard Perlmutter (Ram Lev)

AVERILL PARK, N.Y. (PRWEB)
May 09, 2023

Leonard Perlmutter (Ram Lev), founder and curriculum developer of the American Meditation Institute and a living link in the world’s oldest health and wisdom tradition, will present his comprehensive program of clinically proven practices that reduce stress and burnout at the upcoming 12th annual Physicians CME Conference for Yoga Science as Holistic Mind/Body Medicine. Entitled The Heart and Science of Yoga this 34 CME retreat, accredited by the American Medical Association, will be held October 17-21, 2023 at the Equinox Resort and Spa in Manchester, Vermont, and is open to physicians, PAs, NPs, residents and healthcare executives.

In December of 2022, “Lifestyle Medicine,” the premier international publication of applied lifestyle medicine, published the results of a five-year, peer-reviewed clinical study to evaluate the efficacy of Leonard Perlmutter’s annual Physician Conference curriculum. The findings included the following positive, life-enhancing, health-promoting changes: Burnout was reduced 23.3%, Secondary Traumatic Stress was reduced 19.9%, and Compassion Satisfaction was increased by 11.2%.

Mr. Perlmutter is a noted educator, philosopher, and author of the award-winning books “The Heart and Science of Yoga”® and “YOUR CONSCIENCE,” as well as the “Transformation” journal. Leonard has presented elements of his peer-reviewed proprietary curriculum at the M.D. Anderson Cancer Center, numerous medical schools, Kaiser Permanente, the Commonwealth Club of California, the U. S. Military Academy at West Point and The New York Times Yoga Forum with Dean Ornish MD. Perlmutter’s 45 years of personal study and teaching of Yoga Science and Psychology have prepared him to provide medical professionals a complete set of practical tools to relieve physician stress and burnout, enhance problem solving capacities, and achieve healthier life-work balance.

Acknowledging the current crisis in medicine, conference director Leonard Perlmutter states that, “Each of us is the architect of our own lives, and we determine our destiny. Now, physicians and other healthcare providers have the opportunity to learn clinically proven strategies to reduce their burnout and stress, while increasing their compassion and creativity, and strengthening their decision-making capacity.”

The dedication, enthusiasm, and teaching methodology of the entire AMI faculty create a dynamic and interactive experience for their students. Each faculty member is committed to the advancement and training of Yoga Science as Holistic Mind/Body Medicine. Lecture topics will include AMI Meditation, diaphragmatic breathing, easy-gentle yoga, Yoga psychology, epigenetics and neuroplasticity, resilience, how to use the chakra system as a diagnostic tool, mind function optimization, principles of Ayurveda, plant-based nutrition, and lymph system detoxification. In addition to AMI founder and curriculum developer Leonard Perlmutter, other presenters include: Mark Pettus MD, board certified internist and nephrologist and Director of Medical Education and Population Health of Berkshire Health Systems; Kristin Kaelber MD, PhD, board certified in Internal Medicine and Pediatrics; Renee Rodriguez-Goodemote, MD, Medical Director of the Saratoga Hospital Community Health Center; Anthony Santilli MD, board certified in Pulmonary and Critical Care Medicine; Jesse Ritvo MD, Assistant Medical Director, Inpatient Psychiatry, University of Vermont Health Center; Joshua Zamer, MD, Medical Director for Addiction Medicine at Saratoga Hospital Community Health Center and Chairman of the Department of Family Practice; Jenness Cortez Perlmutter, co-founder and faculty member of The American Meditation Institute; Anita Burock-Stotts, MD, board certified in Internal Medicine; Janine Pardo MD, board certified in Internal Medicine, and Gustavo Grodnitzky PhD, Chair of the AMI Psychological Education Committee.

According to conference alumnus and General Surgeon Lorenz Iannarone MD, “This is a phenomenal conference! Leonard is an excellent teacher, and now an ongoing friend. This experience was so enlightening in comparison to the usual medical conferences which are packed with data, but often not that useful. This teaching has actually changed my life!!! ”

-30-

About the American Meditation Institute

The American Meditation Institute is a 501(c)3 non-profit educational organization devoted to the teaching and practice of Yoga Science, meditation and its allied disciplines as mind/body medicine. In its holistic approach to wellness, AMI combines the healing arts of the East with the practicality of modern Western science. The American Meditation Institute offers a wide variety of courses, conferences and webinars. AMI also publishes “Transformation” a bi-monthly journal of meditation as holistic mind/body medicine. Call 518.674.8714 for a mail or email subscription.

Media Contact:

Robert Washington

60 Garner Road

Averill Park, NY 12018

Tel: 518.674.8714

Fax: 518.674.8714

Share article on social media or email:

“After watching the rapid rise of virtual care and its ability to augment staffing shortages and positively impact patient the experience, MedSitter’s solution stood out. Their culture, values, and Holly’s leadership made joining very easy.”

NOBLESVILLE, Ind. (PRWEB)
May 09, 2023

MedSitter is pleased to announce the appointment of new Senior Vice President of Sales, Michael Jullius. Julius will lead sales and business development initiatives in his new role, collaborating with the leadership team to execute short- and long-term growth strategies.

“The addition of Michael and this new role for MedSitter aligns with our overall expansion strategy in our key markets. His 25 years as a clinician and healthcare administrator, coupled with his strong background in building top-performing sales teams, will be valuable assets to our sales and marketing efforts,” said President Holly Miller. “I believe Michael is the optimal fit for MedSitter’s culture, and he is the right leader to help us achieve our goal as the standard of care for patient observation.”

As a healthcare industry veteran, Julius is recognized for his contributions to enterprise sales strategy and high-performance team development. He takes pride in building long-term, outcomes-based relationships that serve a higher purpose-extraordinary patient care.

“After watching the rapid rise of virtual care and its ability to augment staffing shortages and positively impact patient the experience, MedSitter’s solution stood out. Their culture, values, and Holly’s leadership made joining very easy. I look forward to working with their talented team and leveraging my clinician and administrator experience to strengthen our market position.”

Passionate about the success of others, Julius has sought to fill this desire through servant-leadership roles throughout his career. Most recently, Julius served as the Regional Vice President of Workforce Strategy and Scheduling at AMN Healthcare. During his time, Juilius led the enterprise account team, developing a data-driven approach to deploy caregivers based on patient demand.

Julius will focus on accelerating the go-to-market sales strategy and developing the overall sales team, Positioning MedSitter for high-performance growth alongside Holly Miller, President.

To learn more about MedSitter, visit us online at http://www.MedSitter.com

About MedSitter

MedSitter helps overburdened clinicians to remotely observe patients to meaningfully improve patient safety and satisfaction without straining staff resources. The remote patient observation system is being leveraged by top healthcare systems across the nation with fantastic results. From the first call all the way through account maturity, MedSitter provides exemplary customer support which helps clinicians to proactively meet patient needs. To learn more about MedSitter and the innovative patient safety program it supports, visit http://www.medsitter.com.

For Press Inquiries:

Kate Pascucci

Vice President Marketing

Kate.pascucci@teamids.com

Share article on social media or email:

“This new capability makes Beacon’s custom presentation builder even smarter and more effective to use,” explained Lauren Keyes, Director of Product Management. “MSLs can now spend more time focusing on their scientific engagements without the burden of manual content version management.”

SAN FRANCISCO (PRWEB)
May 09, 2023

Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced a new enhancement to its Beacon scientific exchange platform to better manage source content changes that impact custom presentations created by users. Beacon is a modern content activation and Healthcare Professional (HCP) engagement platform built specifically for Medical Science Liaisons (MSLs), Medical Affairs professionals, and Market Access teams.

Many MSLs currently utilize Beacon’s custom presentation builder feature to combine approved slides and other pieces of content, including rich media, to tailor a personalized scientific exchange to meet individual customer needs. To further enhance this feature, Beacon can now auto-detect slide content deviations from source files using visual comparison technology driven by Artificial Intelligence (AI). Beacon then automatically applies source file content updates to the impacted slides, eliminating work for MSLs and reducing the chance for compliance errors.

This unique capability in the platform helps to directly manage content version differences. This offers both efficiency and accuracy for content administrators and field medical teams.

Additionally, the comparison technology is easily configurable to adhere to each life science company’s compliance policies in terms of timing preferences, notification approaches, and expected actions by their MSLs. All content changes and customer interactions are tracked using robust reporting and analytics in Beacon to inform administrators of applicable oversight and insight-generation needs.

“MSLs seek to deepen HCP relationships through tailored, personalized scientific exchanges that are also compliant. This new capability makes Beacon’s custom presentation builder even smarter and more effective to use,” explained Lauren Keyes, Director of Product Management. “MSLs can now spend more time focusing on their scientific engagements without the burden of manual content version management.”

About Alucio:

Alucio is dedicated to the development of innovative software applications specifically for the life sciences industry. Alucio’s flagship product, Beacon, is a modern, cloud-based scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals. For more information, please visit the company’s website at http://www.alucio.io or contact Lisa Amin at lamin@alucio.io (925) 788-3533.

Share article on social media or email:

Prevent Blindness declares May 15-21, 2023, as the 4th annual “Inherited Retinal Disease (IRD) Genetic Testing Week.”

“By providing IRD patients with the resources they need to learn more about their diagnosis, as well as how gene therapy may benefit them, we are working to continue to preserve vision,” said Jeff Todd, president and CEO of Prevent Blindness.

CHICAGO (PRWEB)
May 09, 2023

Prevent Blindness, the nation’s leading nonprofit eye health and safety organization, has declared May 15-21, 2023, as the fourth annual “Inherited Retinal Disease (IRD) Genetic Testing Week.” An IRD is a genetic disorder that can cause severe vision loss or even blindness. IRDs include Retinitis Pigmentosa (RP), Choroideremia, Stargardt Disease, Cone-rod Dystrophy and Leber Congenital Amaurosis. Early detection and treatment can help to prevent significant vision loss. Genetic testing is now available to identify many gene variants that cause IRDs.

To help raise awareness and educate the public on IRDs and the importance of genetic testing, Prevent Blindness offers a dedicated web resource, PreventBlindness.org/inherited-retinal-diseases. Educational videos, shareable social media graphics, and fact sheets in English and Spanish are available.

On Tuesday, May 16, at 3 p.m. ET, the National Center for Children’s Vision and Eye Health at Prevent Blindness will be hosting the free webinar, “Inherited Retinal Diseases and Children’s Vision and Eye Health: What You Need to Know.” This webinar is designed for a wide audience, including parents and families, school nurses, Head Start and other early childhood program staff, early intervention and special education professionals, teachers of students with visual Impairments, state vision rehabilitation staff, parent and patient support organizations, primary care providers, and eye care providers.

Panelists to include:

• Donna Hunt Hodge, MBA, Director of Marketing, Retina Gene Therapies, Janssen Pharmaceutical Companies of Johnson & Johnson
• Arlene Drack, MD, Ronald Keech Professor of Pediatric Genetic Eye Disease Research, Director, Electrophysiology, Institute for Vision Research, Department of Ophthalmology and Visual Sciences, University of Iowa
• Sherry Day, OD, FAAO, Clinical Assistant Professor, Ophthalmology and Visual Sciences Section Leader, Vision Care, Contact Lens and Low Vision Rehabilitation, University of Michigan
• Kari Branham, MS, CGC, Clinical Assistant Professor, Ophthalmology and Visual Sciences and Genetic Counselor, Inherited Retinal Dystrophy Clinic, University of Michigan
• Mariagrazia Buttitta, MA, NCC, Patient with Cone Dystrophy, and national Certified Counselor, author, motivational speaker, career coach, wellness and health enthusiast, and mental health and disability advocate
• Allison Galloway, FNP-C, MS, SA, Parent of two children with LCA13, a childhood degenerative retinal disease and certified Family Nurse Practitioner, master’s prepared in Food and Science, and a certified Surgery Assistant

Additionally, as part of the Prevent Blindness Focus on Eye Health Expert Series, Alina V. Dumitrescu, M.D., Clinical Associate Professor of Ophthalmology and Visual Sciences, Pediatric Ophthalmology and Strabismus, Inherited Eye Disease at the University of Iowa Hospitals and Clinics, is featured in the episode, “Inherited Retinal Disorders and Genetic Testing.”

Also, two graduates of the ASPECT (Advocacy, Support, Perspective, Empowerment, Communication and Training) Patient Engagement Program at Prevent Blindness, share their perspective and experience of living with an IRD. Brenda Niccum, who has RP, and Mariagrazia Buttitta, who has cone dystrophy, discuss their conditions as well as ways they manage their vision impairments. Founded in 2020, ASPECT aims to equip participants with knowledge, skills, and confidence to become advocates for vision and eye health at the individual, peer-to-peer, community, state and/or national levels.

The 2023 IRD Genetic Testing Week at Prevent Blindness is supported by Janssen Pharmaceutical Companies of Johnson & Johnson and Spark® Therapeutics, a fully integrated company and member of the Roche group. Janssen offers the EyesOnGenes resource, a comprehensive website for patients and health care providers with information on IRDs, genetic testing benefits, community resources and more. Spark offers educational resources on IRDs and genetic testing through the Eye Want 2 Know® website.

Prevent Blindness strongly encourages patients to talk to their eye doctors about genetic testing. Having the genetic diagnosis will help to identify potential treatment options for patients, inform them about the potential risk of disease to other family members and identify the potential risk to other organs in the patient’s body that may be affected.

For those interested in participating, the Prevent Blindness Living Well With Low Vision resource has a dedicated listing of clinical trials for diseases of the retina. The newly redesigned site also provides free resources for low vision patients, including the “Self-help Guide to Non-Visual Skills,” and care partners, such as “The ABCs of Caring for the Visually Impaired.”

“The many recent advancements in treatment for eye diseases have been truly remarkable,” said Jeff Todd, president and CEO of Prevent Blindness. “By providing IRD patients with the resources they need to learn more about their diagnosis, as well as how gene therapy may benefit them, we are working to continue to preserve vision.”

For more information on IRDs and genetic testing for vision issues, visit PreventBlindness.org/inherited-retinal-diseases. To register for the Inherited Retinal Diseases and Children’s Vision and Eye Health: What You Need to Know webinar, visit PreventBlindness.org/ird-webinar. For a listing of vision care financial assistance programs in English or Spanish, visit PreventBlindness.org/vision-care-financial-assistance-information.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at PreventBlindness.org, and follow us on Facebook, Twitter, Instagram, LinkedIn and YouTube.

###

Share article on social media or email:

“I am very thankful to Women We Admire for their recognition of my hard work, as well as for their work inspiring female leaders throughout the country,” said Catherine Downey, founder and CEO of CATMEDIA.

TUCKER, Ga. (PRWEB)
May 09, 2023

CATMEDIA founder and CEO Catherine Downey was recently recognized among The Top 50 Women Leaders of Georgia for 2023 by Women We Admire in their most recent listing.

The Top 50 list was compiled based on a methodical review of women executives and leaders across the area. It includes women from Kohl’s, Deloitte, and University of Georgia.

“It really is a true honor to be on a list with so many strong and successful women,” says Downey.

Downey’s exceptional experience and continued dedication has been recognized through this and numerous other recognitions, including her feature among Atlanta magazine’s 500 most powerful leaders each of the past five years.

Women We Admire Recognizes, Informs, and Inspires

Women We Admire is a membership organization comprised of over 1,200 of the most accomplished women leaders in business, law, consulting, education, non-profit as well as other industries.

They are a provider of news and information about today’s women leaders in business, entertainment, sports, motherhood, medicine, law, and many other industries that covers a variety of topics with the goal of recognizing the achievements of outstanding women. They also aim to inspire others to aim high and to continue towards their full potential.

Women We Admire, and its affiliates, has a reach of over 32,000 individuals and businesses.

About CATMEDIA

CATMEDIA is an award-winning agency that specializes in advertising, creative services, media production, program management, and leadership training. As a national leader that works with highly regulated clients, breaks down complex issues, and effectively communicates to a wide array of audiences, this Women-Owned Small Business (WOSB) provides world-class customer service and innovative solutions to commercial and government clients, alike, including the Centers for Disease Control and Prevention (CDC), Federal Aviation Administration (FAA), and Department of Veterans Affairs (VA).

Share article on social media or email:

John McDonnell, President and CEO of Evive

John is a strong, hands-on leader with a clear understanding of business economics and key value drivers that uniquely position him to take Evive into its next growth stage.

CHICAGO (PRWEB)
May 09, 2023

Evive, the leader in digital engagement and communications technology, today announced that after five years with the company, John McDonnell has been promoted to president and CEO. McDonnell succeeds Prashant Srivastava, who served as president and CEO since 2017 after Peter Saravis, who co-founded Evive with Srivastava in 2007, and was CEO from 2007-2017, stepped down.

Under the new leadership structure, Srivastava will transfer to executive chairman of Evive’s Board of Directors and support the ongoing successful execution of Evive’s long-term strategic plan. Saravis assumed the role of executive chairman in 2017, and will continue to serve on Evive’s Board, maintaining an active role in identifying and planning strategies that drive ongoing growth and product innovation for the company.

“I am tremendously grateful and honored to be the next president and CEO of Evive and follow in Prashant’s footsteps,” said McDonnell. “Prashant has done an outstanding job in this role over the last 16 years and has assembled a great team. Under his leadership, we have reached record growth, have continued to add outstanding talent, and have achieved significant product success within many areas of our business.”

McDonnell joined Evive in 2018, first serving as chief financial officer and adding chief operations officer to his title in December 2019. With over 25 years of business and financial management experience, McDonnell has a successful track record helping companies grow, supporting strategy development and enabling execution.

Previously, McDonnell was CFO at Infogix, Inc., a leading provider of data solutions, where he oversaw finance, revenue management, accounting and risk management. Earlier in his career, John held finance and accounting roles at SAVO and Interface Software.

“John is a strong, hands-on leader with a clear understanding of business economics and key value drivers that uniquely position him to take Evive into its next growth stage,” said Srivastava. “Peter and I started Evive to help employees get more from their benefits and help employers better understand the value of their investment across their entire benefit and resource ecosystem. As we continue to build the leading digital communications and engagement platform serving hundreds of employers and millions of employees each year, we’re confident John has the depth and breadth of experience to continue that mission and capitalize on the many opportunities ahead.”

To learn more about Evive or schedule a demonstration, please visit http://www.goevive.com. To keep up with Evive, read the Evive blog or stay connected by following Evive on LinkedIn.

About Evive

Evive is a digital communications and engagement platform that helps health plans, benefit administrators and employers optimize the benefits, resources and programs they offer their employees. Using data-driven personalization, closed-loop engagement reporting and the power of predictive analytics and behavioral science, Evive increases benefits awareness, engagement and utilization to deliver the right message about the right benefit at the right time. To learn more about Evive, visit http://www.goevive.com or LinkedIn.

Share article on social media or email:

ClinEco Welcomes a New Advisor

ClinEco plans on leaning heavily on Rob’s diverse expertise in the management of online marketplaces and startup growth as we work to deliver the best possible experiences of all clinical research stakeholders.

NEEDHAM, Mass. (PRWEB)
May 09, 2023

ClinEco, the world’s first online community for clinical trial organizations to explore, engage and exchange capabilities with an ecosystem of partners, announced today that it has named Rob Ristagno, President of International Operations at Vistage Worldwide, to its advisory board. In his role, Ristagno will counsel ClinEco leadership as they plan their next chapter of growth for the clinical trial partnership platform.

“We are thrilled to have Rob as one of our advisors. Rob’s experience is different from the rest of our team, as his background is not in clinical research but rather in helping companies grow. This makes him a great complement to the rest of our advisory board and a valuable member of our team,” said Micah Lieberman, Co-Founder and VP of Community and Business Development at ClinEco. “We plan on leaning heavily on Rob’s diverse expertise in the management of online marketplaces and startup growth as we work to deliver the best possible experiences for all our clinical research stakeholders.”

In Ristagno’s current role with Vistage Worldwide, he is focused on building the company’s footprint globally, particularly in Europe, the Middle East and Africa (EMEA) as well as the Latin American and Asia Pacific regions. His previous experience includes building and growing a tech-enabled consultancy, Sterling Woods, where he and his team created over a half billion dollars of enterprise value for small and medium sized businesses. Ristagno’s background also includes time at McKinsey & Company, America’s Test Kitchen and Homesite Insurance in growth-focused executive roles as well as positions at global brands Visa, Pepsi and Comcast. He is a published author, keynote speaker and serves on the board of DRG Holdings. Rob holds an MBA from Harvard Business School and a BA in economics from Dartmouth College and has taught at both Harvard and Boston College.

About ClinEco

ClinEco unites sponsors, CROs, service providers and sites on the world’s first B2B clinical trial marketplace, empowering all to expand clinical partnerships. Through creating a platform where all clinical research stakeholders can explore, engage, and exchange capabilities with an ecosystem of partners, ClinEco accelerates the process of vendor selection, leading to faster, more efficient clinical trials. ClinEco is a Cambridge Healthtech Institute Company. The team responsible for ClinEco is also the team behind the Summit for Clinical Ops Executives (SCOPE).

About CHI

Cambridge Healthtech Institute (CHI) believes bringing together a unique and diverse constellation of innovators, scientists, and life science professionals can hold the key to developing tomorrow’s cures and diagnostics. We are a life science network for leading researchers and business experts from top pharmaceutical, biotech, and academic organizations.

Share article on social media or email: